What if they do not have the capital to take the company to the next step? Have you EVER thought about that? Apparently, this may be your first biotech rodeo. There are expenses. All companies have expenses. The problem with biotechs is that they do not earn money until after a drug gets approved. You know that going in.
Naive "due diligence" merely shows that one can type.
News 
Market Data 
Discover 
